Many prostate cancers that initially respond to hormone therapy with LHRH agonists, LHRH antagonists, or orchiectomy eventually stop responding to this treatment. ... Castration-resistant prostate cancersneed much lower levels of androgen to grow than androgen-sensitive cancers.
